IgG4-RD Strategic Account Manager

Amgen SA; Evanston (IL); On-site; USD 90,000 - 130,000; Full time

Job summary

Amgen seeks an Account Manager/Specialty Account Manager to represent Amgen products to physicians and healthcare professionals, establish product sales, and manage a total territory. You will provide disease information and education to medical professionals and external customers involved in patient care.

The role requires building productive relationships with local, regional, and national KOLs, and developing deep disease knowledge for IgG4-RD, using a consultative selling approach within

Qualifications

• Bachelor's degree and 3 years of sales experience within pharmaceutical, biotech or medical device.

Responsibilities

• Represent Amgen products to physicians and healthcare professionals.
• Establish product sales and perform total territory account management.
• Provide disease information and education to medical professionals and external customers.
• Implement goals of the marketing plan through execution of strategic account business plan.
• Demonstrate experience working in a matrix environment with Case Managers, Medical Affairs, Patient access team, etc.
• Navigate the healthcare landscape to identify opportunities through academia, IDNs, and hospitals.
• Establish productive relationships with local, regional, and national KOLs within the territory.
• Develop in-depth disease and therapeutic knowledge to support IgG4-RD treatment awareness.
• Utilize a consultative selling approach to meet the needs of healthcare professionals treating IgG4-RD.

Education

Bachelor's degree

3 years sales experience

Job description

Amgen seeks an Account Manager/Specialty Account Manager to represent Amgen products to physicians and healthcare professionals, establish product sales, and manage a total territory. You will provide disease information and education to medical professionals and external customers involved in patient care.

The role requires building productive relationships with local, regional, and national KOLs, and developing deep disease knowledge for IgG4-RD, using a consultative selling approach within